Akari therapeutics plc (AKTX)
CashFlow / TTM
Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Cash Flows from Operating Activities:
Net loss

-51,716

-46,606

-45,317

-52,903

-1,016

-1,904

-1,947

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation

-

0

-

0

0

0

-

0

0

0

Stock-based compensation

2,662

1,856

1,039

76

-351

-195

0

0

0

0

Changes in fair value of the liability for options and warrants

0

0

-

-

0

0

-

-

-

-

Foreign currency exchange gains

-

0

-

-

0

0

-

-

-

-

Changes in operating assets and liabilities:
Increase in assets:
Changes in values of liability related to stock options and warrants

-

-

-

-

-

-

-

-

0

0

Prepaid expenses and other current assets

-173

-399

-913

-1,470

-597

-141

8

0

0

0

(Decrease) increase in liabilities:
Accounts payable and accrued expenses

840

161

3,755

0

0

0

-

-

-

-

Other liabilities

9

6

3

0

0

0

-

-

-

-

Total adjustments

36,305

36,188

40,351

0

0

0

-

-

-

-

(Decrease) increase in trade payables

-

-

-

-

-

-

-

-

0

0

Decrease in other accounts payable

-

-

-

-

-

-

-

-

0

0

Increase in other long term liabilities

-

-

-

-

-

-

-

-

0

0

Net Cash Used in Operating Activities

-

0

-

-

-

0

-

0

0

0

Cash Flows from Investing Activities:
Purchase of property and equipment

0

0

-

-

0

0

-

-

-

-

Net Cash (Used in) Provided by Investing Activities

-

0

-

-

-

0

-

0

0

0

Proceeds from issuance of shares, net

-

-

-

-

-

-

-

-

-

0

Net Cash Provided by Financing Activities

-

-

-

-

-

-

-

0

0

0

Effect of Exchange Rates on Cash

95

124

121

0

0

0

-

-

-

-

Net Decrease in Cash

9,461

60,100

65,592

78,720

-4,053

-5,395

2,773

0

0

0

Interest

-

20

-

0

0

0

-

-

-

-